Cargando…
Constipation Mitigation by Rhubarb Extract in Middle-Aged Adults Is Linked to Gut Microbiome Modulation: A Double-Blind Randomized Placebo-Controlled Trial
Gut microbiota alterations are intimately linked to chronic constipation upon aging. We investigated the role of targeted changes in the gut microbiota composition in the relief of constipation symptoms after rhubarb extract (RE) supplementation in middle-aged volunteers. Subjects (95% women, averag...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738964/ https://www.ncbi.nlm.nih.gov/pubmed/36499011 http://dx.doi.org/10.3390/ijms232314685 |
_version_ | 1784847682000388096 |
---|---|
author | Neyrinck, Audrey M. Rodriguez, Julie Taminiau, Bernard Herpin, Florent Cani, Patrice D. Daube, Georges Bindels, Laure B. Delzenne, Nathalie M. |
author_facet | Neyrinck, Audrey M. Rodriguez, Julie Taminiau, Bernard Herpin, Florent Cani, Patrice D. Daube, Georges Bindels, Laure B. Delzenne, Nathalie M. |
author_sort | Neyrinck, Audrey M. |
collection | PubMed |
description | Gut microbiota alterations are intimately linked to chronic constipation upon aging. We investigated the role of targeted changes in the gut microbiota composition in the relief of constipation symptoms after rhubarb extract (RE) supplementation in middle-aged volunteers. Subjects (95% women, average 58 years old) were randomized to three groups treated with RE at two different doses determined by its content of rhein (supplementation of 12.5 mg and 25 mg per day) vs. placebo (maltodextrin) for 30 days. We demonstrated that daily oral supplementation of RE for 30 days was safe even at the higher dose. Stool frequency and consistency, and perceived change in transit problem, transit speed and difficulty in evacuating, investigated by validated questionnaires, were improved in both groups of RE-treated volunteers compared to placebo. Higher abundance of Lachnospiraceae (mainly Roseburia and Agathobacter) only occurred after RE treatment when present at low levels at baseline, whereas an opposite shift in short-chain fatty acid (SCFA) levels was observed in both RE-treated groups (increase) and placebo (decrease). Fecal Lachnospiraceae and SCFA were positively correlated with stool consistency. This study demonstrates that RE supplementation promotes butyrate-producing bacteria and SCFA, an effect that could contribute to relieving chronic constipation in middle-aged persons. |
format | Online Article Text |
id | pubmed-9738964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97389642022-12-11 Constipation Mitigation by Rhubarb Extract in Middle-Aged Adults Is Linked to Gut Microbiome Modulation: A Double-Blind Randomized Placebo-Controlled Trial Neyrinck, Audrey M. Rodriguez, Julie Taminiau, Bernard Herpin, Florent Cani, Patrice D. Daube, Georges Bindels, Laure B. Delzenne, Nathalie M. Int J Mol Sci Article Gut microbiota alterations are intimately linked to chronic constipation upon aging. We investigated the role of targeted changes in the gut microbiota composition in the relief of constipation symptoms after rhubarb extract (RE) supplementation in middle-aged volunteers. Subjects (95% women, average 58 years old) were randomized to three groups treated with RE at two different doses determined by its content of rhein (supplementation of 12.5 mg and 25 mg per day) vs. placebo (maltodextrin) for 30 days. We demonstrated that daily oral supplementation of RE for 30 days was safe even at the higher dose. Stool frequency and consistency, and perceived change in transit problem, transit speed and difficulty in evacuating, investigated by validated questionnaires, were improved in both groups of RE-treated volunteers compared to placebo. Higher abundance of Lachnospiraceae (mainly Roseburia and Agathobacter) only occurred after RE treatment when present at low levels at baseline, whereas an opposite shift in short-chain fatty acid (SCFA) levels was observed in both RE-treated groups (increase) and placebo (decrease). Fecal Lachnospiraceae and SCFA were positively correlated with stool consistency. This study demonstrates that RE supplementation promotes butyrate-producing bacteria and SCFA, an effect that could contribute to relieving chronic constipation in middle-aged persons. MDPI 2022-11-24 /pmc/articles/PMC9738964/ /pubmed/36499011 http://dx.doi.org/10.3390/ijms232314685 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Neyrinck, Audrey M. Rodriguez, Julie Taminiau, Bernard Herpin, Florent Cani, Patrice D. Daube, Georges Bindels, Laure B. Delzenne, Nathalie M. Constipation Mitigation by Rhubarb Extract in Middle-Aged Adults Is Linked to Gut Microbiome Modulation: A Double-Blind Randomized Placebo-Controlled Trial |
title | Constipation Mitigation by Rhubarb Extract in Middle-Aged Adults Is Linked to Gut Microbiome Modulation: A Double-Blind Randomized Placebo-Controlled Trial |
title_full | Constipation Mitigation by Rhubarb Extract in Middle-Aged Adults Is Linked to Gut Microbiome Modulation: A Double-Blind Randomized Placebo-Controlled Trial |
title_fullStr | Constipation Mitigation by Rhubarb Extract in Middle-Aged Adults Is Linked to Gut Microbiome Modulation: A Double-Blind Randomized Placebo-Controlled Trial |
title_full_unstemmed | Constipation Mitigation by Rhubarb Extract in Middle-Aged Adults Is Linked to Gut Microbiome Modulation: A Double-Blind Randomized Placebo-Controlled Trial |
title_short | Constipation Mitigation by Rhubarb Extract in Middle-Aged Adults Is Linked to Gut Microbiome Modulation: A Double-Blind Randomized Placebo-Controlled Trial |
title_sort | constipation mitigation by rhubarb extract in middle-aged adults is linked to gut microbiome modulation: a double-blind randomized placebo-controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738964/ https://www.ncbi.nlm.nih.gov/pubmed/36499011 http://dx.doi.org/10.3390/ijms232314685 |
work_keys_str_mv | AT neyrinckaudreym constipationmitigationbyrhubarbextractinmiddleagedadultsislinkedtogutmicrobiomemodulationadoubleblindrandomizedplacebocontrolledtrial AT rodriguezjulie constipationmitigationbyrhubarbextractinmiddleagedadultsislinkedtogutmicrobiomemodulationadoubleblindrandomizedplacebocontrolledtrial AT taminiaubernard constipationmitigationbyrhubarbextractinmiddleagedadultsislinkedtogutmicrobiomemodulationadoubleblindrandomizedplacebocontrolledtrial AT herpinflorent constipationmitigationbyrhubarbextractinmiddleagedadultsislinkedtogutmicrobiomemodulationadoubleblindrandomizedplacebocontrolledtrial AT canipatriced constipationmitigationbyrhubarbextractinmiddleagedadultsislinkedtogutmicrobiomemodulationadoubleblindrandomizedplacebocontrolledtrial AT daubegeorges constipationmitigationbyrhubarbextractinmiddleagedadultsislinkedtogutmicrobiomemodulationadoubleblindrandomizedplacebocontrolledtrial AT bindelslaureb constipationmitigationbyrhubarbextractinmiddleagedadultsislinkedtogutmicrobiomemodulationadoubleblindrandomizedplacebocontrolledtrial AT delzennenathaliem constipationmitigationbyrhubarbextractinmiddleagedadultsislinkedtogutmicrobiomemodulationadoubleblindrandomizedplacebocontrolledtrial |